Cargando…
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962272/ https://www.ncbi.nlm.nih.gov/pubmed/21042422 http://dx.doi.org/10.2147/IJN.S12415 |
_version_ | 1782189180273557504 |
---|---|
author | Kalantarian, Pardis Najafabadi, Abdolhosein Rouholamini Haririan, Ismaeil Vatanara, Alireza Yamini, Yadollah Darabi, Majid Gilani, Kambiz |
author_facet | Kalantarian, Pardis Najafabadi, Abdolhosein Rouholamini Haririan, Ismaeil Vatanara, Alireza Yamini, Yadollah Darabi, Majid Gilani, Kambiz |
author_sort | Kalantarian, Pardis |
collection | PubMed |
description | This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane, acetone, or ethanol were used for particle preparation, and their effects on the physical characteristics of the final products were studied. The conditions of the experiment included pressures of 100 and 150 bar, temperature of 40°C, and a flow rate of 1 mL/min. The particles were characterized physicochemically before and after the process for their morphology and crystallinity. In spite of differences in size, the particles were not very different regarding their morphology. The resulting particles were of a regular shape, partly spherical, and appeared to have a smooth surface, whereas the mechanically milled particles showed less uniformity, had surface irregularities and a high particle size distribution, and seemed aggregated. Particles of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 nm. In order to evaluate the aerodynamic behavior of the nanoparticles, six 5-FU dry powder formulations containing mixtures of coarse and fine lactose of different percentages were prepared. Deposition of 5-FU was measured using a twin-stage liquid impinger and analyzed using a validated high pressure liquid chromatography method. Addition of fine lactose improved the aerodynamic performance of the drug, as determined by the fine particle fraction. |
format | Text |
id | pubmed-2962272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29622722010-11-01 Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery Kalantarian, Pardis Najafabadi, Abdolhosein Rouholamini Haririan, Ismaeil Vatanara, Alireza Yamini, Yadollah Darabi, Majid Gilani, Kambiz Int J Nanomedicine Original Research This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane, acetone, or ethanol were used for particle preparation, and their effects on the physical characteristics of the final products were studied. The conditions of the experiment included pressures of 100 and 150 bar, temperature of 40°C, and a flow rate of 1 mL/min. The particles were characterized physicochemically before and after the process for their morphology and crystallinity. In spite of differences in size, the particles were not very different regarding their morphology. The resulting particles were of a regular shape, partly spherical, and appeared to have a smooth surface, whereas the mechanically milled particles showed less uniformity, had surface irregularities and a high particle size distribution, and seemed aggregated. Particles of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 nm. In order to evaluate the aerodynamic behavior of the nanoparticles, six 5-FU dry powder formulations containing mixtures of coarse and fine lactose of different percentages were prepared. Deposition of 5-FU was measured using a twin-stage liquid impinger and analyzed using a validated high pressure liquid chromatography method. Addition of fine lactose improved the aerodynamic performance of the drug, as determined by the fine particle fraction. Dove Medical Press 2010-10-05 2010 /pmc/articles/PMC2962272/ /pubmed/21042422 http://dx.doi.org/10.2147/IJN.S12415 Text en © 2010 Kalantarian et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Kalantarian, Pardis Najafabadi, Abdolhosein Rouholamini Haririan, Ismaeil Vatanara, Alireza Yamini, Yadollah Darabi, Majid Gilani, Kambiz Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title | Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title_full | Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title_fullStr | Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title_full_unstemmed | Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title_short | Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
title_sort | preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962272/ https://www.ncbi.nlm.nih.gov/pubmed/21042422 http://dx.doi.org/10.2147/IJN.S12415 |
work_keys_str_mv | AT kalantarianpardis preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT najafabadiabdolhoseinrouholamini preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT haririanismaeil preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT vatanaraalireza preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT yaminiyadollah preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT darabimajid preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery AT gilanikambiz preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery |